Sibeprenlimab, a new APRIL blocker, cuts proteinuria in IgA nephropathy.
Ahlam A. Ayyad, PharmD
Advertisement
Articles by Ahlam A. Ayyad, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5